Calamos Advisors LLC Makes New Investment in BrightSpring Health Services, Inc. $BTSG

Key Points

• Calamos Advisors opened a position in BrightSpring Health Services during the third quarter, buying 22,963 shares valued at approximately $1.3 million.
• Analyst sentiment is broadly positive: the stock has a consensus Buy rating and a $77.81 consensus price target; UBS raised its target to $92 and Wells Fargo to $82.
• BrightSpring reported quarterly earnings of $0.54 per share, beating the $0.47 estimate, while revenue of $4.21 billion exceeded expectations and rose 26.4% year over year.

Calamos Advisors LLC bought a new stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 22,963 shares of the company's stock, valued at approximately $1,303,000.

Several other institutional investors and hedge funds have also modified their holdings of BTSG. TD Waterhouse Canada Inc. purchased a new stake in shares of BrightSpring Health Services during the second quarter worth $22,054,000. Bank of America Corp DE boosted its position in BrightSpring Health Services by 48.7% during the first quarter. Bank of America Corp DE now owns 1,534,154 shares of the company's stock valued at $65,370,000 after purchasing an additional 502,786 shares during the last quarter. Ausbil Investment Management Ltd acquired a new stake in BrightSpring Health Services during the second quarter valued at $2,005,000. Bellars Harris Wealth Management LLC purchased a new position in BrightSpring Health Services in the second quarter valued at about $4,394,000. Finally, Tidal Investments LLC grew its stake in BrightSpring Health Services by 186.2% in the second quarter. Tidal Investments LLC now owns 68,900 shares of the company's stock valued at $4,805,000 after purchasing an additional 44,828 shares in the last quarter.

Analyst Ratings Changes

Several research analysts have weighed in on BTSG shares. Wells Fargo & Company upped their target price on BrightSpring Health Services from $78.00 to $82.00 and gave the stock an "overweight" rating in a research report on Monday, November 2nd. UBS Group raised their price target on BrightSpring Health Services from $85.00 to $92.00 and gave the stock a "buy" rating in a research note on Monday, November 2nd. BTIG Research reiterated a "buy" rating and set a $90.00 price target on shares of BrightSpring Health Services in a report on Thursday, August 13th. KeyCorp reissued an "overweight" rating on shares of BrightSpring Health Services in a research note on Monday, August 3rd. Finally, Wall Street Zen raised BrightSpring Health Services from a "buy" rating to a "strong-buy" rating in a research note on Saturday, October 31st. Two research analysts have rated the stock with a Strong Buy rating and seventeen have issued a Buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $77.81.

BrightSpring Health Services Trading Up 3.0%

Shares of NASDAQ:BTSG opened at $69.15 on Tuesday. The stock has a market capitalization of $13.76 billion, a PE ratio of 37.38, a P/E/G ratio of 0.79 and a beta of 1.77. BrightSpring Health Services, Inc. has a 1 year low of $30.64 and a 1 year high of $73.75. The firm has a fifty day moving average price of $60.96 and a 200 day moving average price of $55.41. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.99.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last posted its earnings results on Friday, October 30th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.47 by $0.07. BrightSpring Health Services had a net margin of 2.69% and a return on equity of 18.56%. The firm had revenue of $4.21 billion for the quarter, compared to the consensus estimate of $3.88 billion. BrightSpring Health Services's revenue was up 26.4% compared to the same quarter last year. Analysts expect that BrightSpring Health Services, Inc. will post 1.70 EPS for the current fiscal year.

BrightSpring Health Services Profile

BrightSpring Health Services is a provider of home- and community-based health services in the United States. The company supports people with complex health needs, including individuals with intellectual and developmental disabilities, behavioral health conditions, and chronic or age-related illnesses.

Its services include home health and hospice care, behavioral health and rehabilitation, residential and community-based support, and pharmacy services. BrightSpring's pharmacy operations provide prescription dispensing and related services to people receiving care in homes, community settings, and long-term care facilities.

Headquartered in Louisville, Kentucky, BrightSpring operates across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.